Medexus Pharmaceuticals (Medexus Pharmaceuticals) Deferred Tax : $-6.8 Mil (TTM As of Dec. 2023)

View and export this data going back to 2017. Start your Free Trial

What is Medexus Pharmaceuticals Deferred Tax?

Change In Deferred Tax represents future tax liability or asset, resulting from temporary differences between book (accounting) value of assets and liabilities, and their tax value. This arises due to differences between financial accounting for shareholders and tax accounting.

Medexus Pharmaceuticals's change in deferred tax for the three months ended in Dec. 2023 was $-0.3 Mil. Its change in deferred tax for the trailing twelve months (TTM) ended in Dec. 2023 was $-6.8 Mil.

Medexus Pharmaceuticals Deferred Tax Historical Data

The historical data trend for Medexus Pharmaceuticals's Deferred Tax can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Medexus Pharmaceuticals Deferred Tax Chart

Medexus Pharmaceuticals Annual Data

Trend

Dec13

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Deferred Tax

Get a 7-Day Free Trial

0.17

-0.84

-3.24

-0.94

-6.26

Medexus Pharmaceuticals Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Deferred Tax	Get a 7-Day Free Trial															0.55	-6.84	0.23	0.12	-0.26

Medexus Pharmaceuticals Deferred Tax Calculation

Deferred Tax for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-6.8 Mil.

Medexus Pharmaceuticals Deferred Tax Related Terms

Thank you for viewing the detailed overview of Medexus Pharmaceuticals's Deferred Tax provided by GuruFocus.com. Please click on the following links to see related term pages.

Medexus Pharmaceuticals (Medexus Pharmaceuticals) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Medexus Pharmaceuticals Inc (OTCPK:MEDXF) » Definitions » Deferred Tax

Comparable Companies

Traded in Other Exchanges

P731:Germany MDP:Canada

Address

35 Nixon Road, Suite 1, Bolton, ON, CAN, L7E 1K1

Website

https://www.medexus.com

Medexus Pharmaceuticals Inc is an innovative and rare disease pharmaceutical company with a strong North American commercial platform and a portfolio of proven best-in-class products. The company's focus is on the therapeutic areas of hematology, auto-immune diseases, and allergy.